Forget about injectables B'dog as hottod so unwittingly illustrated tocopherol phosphate use with injectables despite a huge amount of research over many years has failed to produce a commercial product . The Japanese are just researching out of curiosity imo .
The costs payable to Mylan should drive the final stake in this zombie . A claimant losing each and every claim wont see any mitigation of costs imo .
- Forums
- ASX - By Stock
- POH
- Ann: Receipt of R&D Tax Incentive
Ann: Receipt of R&D Tax Incentive, page-11
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
POH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online